MIRA PHARMACEUTICALS, INC. - 29 Sep 2025 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

SEC form
3
Accepted by SEC
03 Oct 2025, 20:00:15 UTC
Source filing
View source filing
Filing notes and source

Key filing fact

MIRA PHARMACEUTICALS, INC. filed Form 3 for Telomir Pharmaceuticals, Inc. (TELO) on 03 Oct 2025.

Key facts

  • This page summarizes MIRA PHARMACEUTICALS, INC.'s Form 3 filing for Telomir Pharmaceuticals, Inc. (TELO).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Oct 2025, 20:00.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001904286 Primary reporting owner

MIRA PHARMACEUTICALS, INC.

Relationship
10%+ Owner

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELO holding

Common Stock, no par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,521,127
Date
29 Sep 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents 3,521,127 shares of the Issuer's common stock, no par value, acquired in connection with the Reporting Person's acquisition of SKNY Pharmaceuticals, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .